CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Sociedade Beneficente de Senhoras (SBSHSL). Hospital Sírio-Libanês (Institutional affiliation for the last research proposal) Birthplace: Brazil
Graduated in Dentistry at Universidade Federal do Rio Grande do Sul (2001) and concluded PhD in human genetics at Universidade de São Paulo (2007). Has experience in human genetics, molecular biology, and bioinformatics. Concluded three post-doctorals: in 20009, at Ludwig Institute for Cancer Research (São Paulo branch), supervised by Dr. Anamaria Camargo; in 2012, at Universidade de São Paulo, supervised by Dr. Maria Rita Passos-Bueno; and, in 2014, at the University of Geneva, Switzerland, supervised by Dr. Emmanouil Dermitzakis. Works at the Molecular Oncology Center, at Instituto Sirio-Libanes de Ensino e Pesquisa, Sao Paulo, Brazil, as Researcher-I (email: cmasotti@mochsl.org.br). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Bladder cancer is the 9th most common cancer in the world and 70-80% of cases correspond to non-invasive bladder cancer (NMIBC). NMIBC treatment is surgical (tumor transurethral scraping) followed by adjuvant immunotherapy. In order to reduce the recurrence risk of the disease, immunotherapy is performed through intra-vesical applications of the tuberculosis vaccine BCG (Bacillus Calmette…
The most common type of bladder cancer is the non invasive form, not reaching muscular tissue (non muscle invasive bladder cancer, NMIBC), corresponding to 70-80% of cases. NMIBC treatment is cirurgical (transurethral resection of the bladder, TURB), followed by immunotherapy with BCG (Bacillus Calmette-Guerin) vaccine in cases with high or intermediate recurrence risk. The recurrence ris…
| 1 / 1 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 5 / 0 | Completed scholarships in Brazil |
| 7 / 2 | All research grants and scholarships |
| Associated processes | |